Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26834949 |
US |
57 | 2 |
Lip pruritus, Oral discomfort, Urticaria, Asthma, Wheezing, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 602 | 26834960 |
US |
72 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 603 | 26835198 |
US |
1 | |
Illness, Asthma, |
||||
DUPILUMAB, DUPILUMAB, TERIPARATIDE, LOTILANER OPHTHALMIC SOLUTION, |
||||
| 604 | 26835486 |
US |
2 | |
Asthma, Cough, Dysphonia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, MEPOLIZUMAB, |
||||
| 605 | 26835487 |
US |
62 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 606 | 26835756 |
US |
52 | 2 |
Sleep disorder due to a general medical condition, Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 607 | 26836082 |
US |
36 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, DUPILUMAB, BENRALIZUMAB, |
||||
| 608 | 26836465 |
US |
64 | 2 |
Asthma, Escherichia infection, Asthenia, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 609 | 26836486 |
US |
53 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 610 | 26836724 |
US |
2 | |
Ulcer, Hypersensitivity, Chest pain, Nasal septum deviation, Dyspnoea, Pain in jaw, Abdominal pain upper, Inappropriate schedule of product administration, Pruritus, Rash, Asthma, Cardiac aneurysm, Syncope, |
||||
OMALIZUMAB, |
||||
| 611 | 26836838 |
US |
2 | |
Eczema, Skin exfoliation, Asthma, |
||||
DUPILUMAB, |
||||
| 612 | 26837205 |
US |
42 | 2 |
Influenza like illness, Nasopharyngitis, Asthma, |
||||
DUPILUMAB, |
||||
| 613 | 26837248 |
CA |
2 | |
Lower respiratory tract infection, Asthma, |
||||
DUPILUMAB, DUPILUMAB, CICLESONIDE, RISPERIDONE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BACLOFEN, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, MIRABEGRON, |
||||
| 614 | 26837301 |
US |
1 | |
Device delivery system issue, Device use issue, Overdose, Product dose omission issue, Asthma, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 615 | 26837378 |
US |
2 | |
Asthma, Pneumonia, Accident, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 616 | 26837559 |
US |
51 | 2 |
Psoriasis, Inflammation, Asthma, Injection site pain, |
||||
DUPILUMAB, |
||||
| 617 | 26837972 |
US |
61 | 1 |
Asthma, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE, DOXEPIN, DOXEPIN HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, HYDROXYZINE, DOXEPIN HYDROCHLORIDE, DOXEPN HYDROCHLORIDE, AMLODIPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 618 | 26838036 |
US |
2 | |
Peripheral swelling, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 619 | 26838212 |
US |
75 | 2 |
Asthma, Therapeutic response unexpected, |
||||
DUPILUMAB, |
||||
| 620 | 26838767 |
TT |
47 | 2 |
Asthma, Oral mucosal exfoliation, Oral mucosal blistering, Oral pain, Throat irritation, Inappropriate schedule of product administration, |
||||
| 621 | 26838840 |
CA |
34 | 2 |
Asthma, Chest pain, Cough, Dyspnoea, Drug hypersensitivity, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
OMALIZUMAB, CLONAZEPAM, RITUXIMAB, PREDNISONE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, ERGOCALCIFEROL, RISEDRONATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, TRAMADOL HYDROCHLORIDE, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 622 | 26838950 |
US |
79 | 1 |
Asthma, Cough, Dry eye, Infection, |
||||
DUPILUMAB, |
||||
| 623 | 26838975 |
US |
2 | |
Food allergy, Off label use, Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 624 | 26839063 |
CA |
57 | 1 |
Pneumonia, Bronchospasm, Asthma, Product dose omission issue, |
||||
RESLIZUMAB, ALBUTEROL SULFATE, ERGOCALCIFEROL, MONTELUKAST, FLUTICASONE FUROATE, TIOTROPIUM BROMIDE, |
||||
| 625 | 26839185 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Erythema, Asthma, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, IVABRADINE, HYDROXYCHLOROQUINE, TIZANIDINE HYDROCHLORIDE, TACROLIMUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOLIC ACID, |
||||
| 626 | 26839358 |
US |
66 | 1 |
Oropharyngeal pain, Headache, Dysarthria, Dysphagia, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ORAL SEMAGLUTIDE, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, ALBUTEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BENZONATATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ERGOCALCIFEROL, FUROSEMIDE, OLMESARTAN MEDOXOMIL, |
||||
| 627 | 26839362 |
US |
2 | |
Critical illness, Asthma, |
||||
| 628 | 26829906 |
CA |
65 | 1 |
Lower respiratory tract infection, Asthma, Upper respiratory tract infection, |
||||
ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 629 | 26829921 |
US |
58 | 1 |
Bronchitis, Asthma, |
||||
DUPILUMAB, |
||||
| 630 | 26830166 |
US |
53 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 631 | 26830169 |
US |
2 | |
Asthma, Product dose omission issue, Scratch, Skin haemorrhage, Injection site urticaria, Pruritus, Injection site swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 632 | 26830174 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 633 | 26830356 |
CA |
60 | 1 |
Asthma, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Malaise, Eosinophilic granulomatosis with polyangiitis, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Full blood count abnormal, Paraesthesia, Productive cough, Vasculitis, Visual impairment, Upper respiratory tract infection, Neuropathy peripheral, Cough, Therapeutic product effect incomplete, Product use in unapproved indication, |
||||
ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, GLYCOPYRROLATE, RANIBIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 634 | 26830570 |
US |
2 | |
Asthma, Myalgia, Arthralgia, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 635 | 26830697 |
US |
62 | 2 |
Rash vesicular, Pruritus, Asthma, |
||||
DUPILUMAB, |
||||
| 636 | 26830819 |
CN |
30 | 1 |
Asthma, Chest discomfort, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 637 | 26831026 |
US |
||
Cough, Asthma, Drug dose omission by device, Device delivery system issue, Product use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 638 | 26831036 |
US |
2 | |
Viral infection, Asthma, |
||||
RISANKIZUMAB-RZAA, |
||||
| 639 | 26831156 |
JP |
58 | 2 |
Breast cancer, Neoplasm malignant, Asthma, Acute sinusitis, Bronchitis, Chronic sinusitis, COVID-19, Off label use, |
||||
THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, DEXTROMETHORPHAN HYDROBROMIDE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, NIFEDIPINE, NIFEDIPINE, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 640 | 26831173 |
US |
||
Inability to afford medication, Asthma, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 641 | 26831205 |
US |
37 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 642 | 26831587 |
US |
60 | 2 |
Thyroid cancer, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 643 | 26831778 |
US |
69 | 2 |
Asthma, Lower respiratory tract infection, Hypersensitivity, Multiple allergies, Bronchitis, Illness, |
||||
UPADACITINIB, |
||||
| 644 | 26831857 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 645 | 26831864 |
US |
37 | 2 |
Sinusitis, Asthma, Wheezing, Cough, |
||||
DUPILUMAB, |
||||
| 646 | 26832064 |
US |
1 | |
Asthma, Wrong technique in product usage process, Device delivery system issue, Incorrect dose administered by device, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, ALBUTEROL SULFATE AND BUDESONIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 647 | 26832310 |
EU |
10 | 2 |
Asthma, Drug ineffective, Incorrect dose administered, Device use error, |
||||
ALBUTEROL SULFATE, |
||||
| 648 | 26832470 |
US |
35 | 2 |
Gastrointestinal haemorrhage, Hiatus hernia, Gastritis, Anaemia, Asthma, Gastrooesophageal reflux disease, Fatigue, Dizziness, Abdominal pain upper, Viral infection, |
||||
TOLVAPTAN, TOLVAPTAN, LISINOPRIL, LISINOPRIL, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, BUDESONIDE, ESOMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE, MONTELUKAST SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, POLYETHYLENE GLYCOL 3350, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, SODIUM FERRIC GLUCONATE COMPLEX, PANTOPRAZOLE SODIUM, |
||||
| 649 | 26832697 |
US |
||
Asthma, Insurance issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 650 | 26832756 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, |
||||
| 651 | 26832875 |
CA |
34 | 2 |
Drug hypersensitivity, Asthma, Chest pain, Cough, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, RISEDRONATE SODIUM, BECLOMETHASONE DIPROPIONATE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, PREDNISONE, TRAMADOL HYDROCHLORIDE, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 652 | 26833166 |
US |
57 | 2 |
Product quality issue, Device malfunction, Dyspnoea, Drug ineffective, Asthma, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 653 | 26833309 |
CA |
2 | |
Pneumonia, Dyspnoea, Drug hypersensitivity, Vomiting, Oedema, Wheezing, Asthma, |
||||
AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, PREDNISONE, FOLIC ACID, OCRELIZUMAB, MONTELUKAST, CALCIUM, CLONAZEPAM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, RISEDRONATE SODIUM, ERGOCALCIFEROL, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, TRAMADOL HYDROCHLORIDE, |
||||
| 654 | 26833329 |
CA |
43 | 2 |
Urticaria, Anti-cyclic citrullinated peptide antibody positive, Asthenia, Asthma, Blood cholesterol increased, Chest pain, Decreased appetite, Gait inability, Injury, Lower limb fracture, Mobility decreased, Nausea, Off label use, Prescribed underdose, Road traffic accident, Sciatica, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, CELECOXIB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VITAMIN C, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, |
||||
| 655 | 26833917 |
US |
5 | 2 |
Molluscum contagiosum, Asthma, |
||||
DUPILUMAB, |
||||
| 656 | 26833919 |
US |
78 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 657 | 26833926 |
US |
2 | |
Asthma, Drug ineffective, |
||||
| 658 | 26834410 |
US |
1 | |
Acne, Myalgia, Asthma, Dry skin, |
||||
DUPILUMAB, |
||||
| 659 | 26824990 |
CO |
2 | |
Spinal fracture, Heart valve replacement, Dental discomfort, Toothache, Sleep apnoea syndrome, Asthma, |
||||
DENOSUMAB, |
||||
| 660 | 26825015 |
US |
63 | 2 |
Asthma, Dyspnoea, Cough, Chest discomfort, Abdominal pain, Frequent bowel movements, Dry mouth, |
||||
DUPILUMAB, |
||||
| 661 | 26825156 |
JP |
81 | 2 |
Pneumonia, Hospitalisation, Dyspnoea, Chronic obstructive pulmonary disease, Bronchitis, Asthma, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OLMESARTAN MEDOXOMIL, ERYTHROMYCIN, |
||||
| 662 | 26825212 |
US |
61 | 2 |
Nephrolithiasis, Pneumonia, Hernia, Muscle spasms, Nausea, Vomiting, Intervertebral disc protrusion, Road traffic accident, Constipation, Flatulence, Cough, Injection site haemorrhage, Injection site pain, Asthma, Oesophageal operation, |
||||
DUPILUMAB, |
||||
| 663 | 26825222 |
US |
2 | |
Injection site erythema, Asthma, |
||||
DUPILUMAB, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHOCARBAMOL, METHOCARBAMOL TABLETS, NORETHINDRONE AND ETHINYL ESTRADIOL, |
||||
| 664 | 26825240 |
US |
15 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 665 | 26825421 |
US |
91 | 1 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 666 | 26825593 |
CA |
7 | |
Asthma, Bronchiolitis, Bronchiectasis, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 667 | 26826216 |
71 | 2 | |
Blood pressure decreased, Asthma, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 668 | 26826285 |
US |
2 | |
Transient ischaemic attack, Asthma, Aortic aneurysm, Seasonal allergy, |
||||
DENOSUMAB, |
||||
| 669 | 26826301 |
GB |
71 | 2 |
Asthma, Blood pressure decreased, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 670 | 26826550 |
CA |
71 | 1 |
Asthma, Off label use, |
||||
INFLIXIMAB-AXXQ, RISANKIZUMAB-RZAA, |
||||
| 671 | 26826672 |
US |
2 | |
Ligament rupture, Pain, Asthma, |
||||
DUPILUMAB, |
||||
| 672 | 26826963 |
US |
65 | 2 |
Asthma, |
||||
DUPILUMAB, AZELASTINE, EPINEPHRINE, ADRENALINUM, FLUTICASONE PROPIONATE, HYDROCHLOROTHIAZIDE, |
||||
| 673 | 26827476 |
CA |
52 | |
Fall, Dehydration, Syncope, Foreign body in eye, Asthma, Weight increased, Herpes zoster, Pain, Off label use, Inappropriate schedule of product administration, Drug ineffective, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 674 | 26827693 |
US |
2 | |
Sleep disorder due to a general medical condition, Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, EPINEPHRINE, MUPIROCIN, MUPIROCIN CALCIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 675 | 26827719 |
US |
11 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 676 | 26827723 |
US |
36 | 2 |
Ankylosing spondylitis, Injection site urticaria, Asthma, Arthralgia, |
||||
DUPILUMAB, |
||||
| 677 | 26828044 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 678 | 26828175 |
56 | 2 | |
Systemic lupus erythematosus, Cushing^s syndrome, Asthma, Dysphonia, Injection site erythema, Blood glucose increased, Headache, Fatigue, Terminal insomnia, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 679 | 26828529 |
US |
1 | |
Asthma, Therapeutic product effect incomplete, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 680 | 26828910 |
US |
2 | |
Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 681 | 26828937 |
CA |
1 | |
Asthma, |
||||
MEPOLIZUMAB, |
||||
| 682 | 26829033 |
US |
2 | |
Paralysis, Asthma, Dyspnoea, Contraindicated product prescribed, |
||||
LEVODOPA, |
||||
| 683 | 26829068 |
US |
54 | 2 |
Pneumonia bacterial, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 684 | 26829387 |
US |
61 | 2 |
Asthma, Inappropriate schedule of product administration, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, SIROLIMUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 685 | 26919700 |
2 | ||
Lymphadenopathy, Peripheral swelling, Asthma, Drug effect less than expected, |
||||
TEZEPELUMAB-EKKO, GABAPENTIN, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 686 | 26819388 |
US |
10 | 2 |
Bronchitis, Asthma, Urticaria, |
||||
DUPILUMAB, |
||||
| 687 | 26819784 |
US |
2 | |
Anxiety, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 688 | 26819835 |
US |
28 | 1 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE, GABAPENTIN, |
||||
| 689 | 26820016 |
US |
36 | 1 |
Arthralgia, Fatigue, Back pain, Asthma, |
||||
PREDNISONE, PEGCETACOPLAN, |
||||
| 690 | 26820123 |
US |
53 | 2 |
Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 691 | 26820312 |
US |
37 | 1 |
Abdominal discomfort, Asthma, Eosinophilic oesophagitis, |
||||
DUPILUMAB, |
||||
| 692 | 26821009 |
US |
58 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 693 | 26821340 |
CA |
79 | 1 |
Dyspnoea, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ACETYLCYSTEINE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CICLESONIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, APIXABAN, ALBUTEROL SULFATE, |
||||
| 694 | 26821366 |
US |
5 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 695 | 26821729 |
US |
54 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 696 | 26821841 |
65 | ||
Myocardial infarction, Acute myocardial infarction, Hypotension, Asthma, Non-cardiac chest pain, Dizziness, Somnolence, Tooth disorder, Toothache, Prostatic specific antigen increased, Mental disorder, Ejection fraction decreased, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 697 | 26822107 |
US |
21 | 2 |
Psoriasis, Rash erythematous, Pruritus, Skin burning sensation, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, SECUKINUMAB, |
||||
| 698 | 26822591 |
US |
45 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 699 | 26822595 |
CN |
59 | 2 |
Chest discomfort, Dyspnoea, Asthma, |
||||
ISATUXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 700 | 26822884 |
US |
2 | |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ESCITALOPRAM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30